Anil Matai, Director General of OPPI, on the Future of Indian Pharma: From Product Provider to Health Partner Read more
Panel Discussion: Future-ready formulations: Addressing the challenges of special populations Read more
Panel Discussion: Topical and transdermal drug delivery: The rise of non-invasive therapies Read more
Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development Read more